Overview

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
Primary objective: • Develop and validate a tool towards patients with chronic hepatitis C genotype 1 and 4 to allow optimize treatment.
Details
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Treatments:
Interferon-alpha
Peginterferon alfa-2a
Ribavirin